The announcement details the progress of Wanbangde Pharmaceutical Holdings Group Co., Ltd.'s share buyback plan approved on May 14, 2026. The buyback amount is set between RMB 40 million and 80 million, with a maximum price of RMB 42 per share. As of May 31, 2026, the company has not yet initiated the buyback. The company will continue to implement the plan based on market conditions and fulfill disclosure obligations.
Summary generated by AI · Always verify with source document
Securities Code: 002082
Securities Abbreviation: ST Wanbang
Announcement Number: 2026-044
Wanbangde Pharmaceutical Holdings Group Co., Ltd. (hereinafter referred to as "the Company") and all members of the Board of Directors guarantee that the content of this information disclosure is true, accurate, and complete, without false records, misleading statements, or significant omissions.
Sign in to read the full translation
Free accounts get 10 full releases per month. Pro subscribers get unlimited access.